Press

Media kit and contact.

TitrateLab is a research intelligence platform for the grey-market peptide economy. Reach out for interviews, data partnerships, or independent verification of our corpus.

Boilerplate

One-paragraph description.

Copy-pasteable, rendered in monospace so whitespace round-trips cleanly into your CMS.

Copy
TitrateLab is a citation-first research-peptide intelligence platform. Our
live corpus covers 11,227 third-party tested batches across 277 manufacturers,
27 documented vendor incidents, and a growing archive of community discussion
enriched with sentiment analysis. Every factual claim on the platform cites
back to the specific COA, incident record, or forum post it came from. Founded
2026. Platform open — registration live.
Contact

Press inquiries.

One inbox for media; response within 48 hours. For corrections against the published record, use corrections@titratelab.com instead — the press inbox won't route that right.

Press & media
press@titratelab.com

Response within 48 hours.

Founder

Who to quote.

Pseudonymous founder. The team operates under the TitrateLab brand only.

TitrateLab Founder · TitrateLab

Available for on-record interviews under the TitrateLab brand. Not available for identity disclosure; any reporting that treats the pseudonym as a gating condition will be politely declined. Happy to speak to the data, the incidents archive, regulatory context, or the research methodology.

Assets

Logo, wordmark, OG image.

Self-host the SVGs below. Email press@titratelab.com if you need higher-resolution rasters, an alternate lockup, or a specific background-color variant for print.

Coverage

Previous coverage.

None yet. Curating this surface as coverage lands.
NOW OPEN

TitrateLab is open.

Create a free account to read the full corpus and run the COA tools. Go Pro for $33 once — lifetime, launch pricing.

Pro · $33 lifetime launch pricing — see what's included. Free accounts read the full corpus and run the COA tools.